Tnkase and pulmonary haemorrhage Patient Reports February 12, 2012

Tnkase Side Effects Report #4645948-8
Tnkase side effect was reported by a Pharmacist from on Apr 22, 2005. Female patient, 76 years of age, weighting 148.0 lb, was diagnosed with pulmonary embolism  and was treated with Tnkase. After drug was administered, patient experienced the following side effects: post procedural complication, pulmonary embolism , pulmonary haemorrhage. Tnkase dosage: 5 MG INFUSED DIRECTLY TO CLOT SITE IN UPPER LOBE. During the same period patient was treated with WARFARIN, TEMAZEPAM, ARGATROBAN. Patient died.

Tnkase Side Effects Report #4740418-0
Tnkase side effect was reported by a Pharmacist from UNITED STATES on Apr 21, 2005. Female patient, 76 years of age, was diagnosed with pulmonary embolism  and was treated with Tnkase. After drug was administered, patient experienced the following side effects: pulmonary haemorrhage. Tnkase dosage: unknown. Patient died.

Tnkase Side Effects Report #4740753-6
Tnkase side effect was reported by a Pharmacist from UNITED STATES on Apr 21, 2005. Female patient, 76 years of age, was diagnosed with pulmonary embolism  and was treated with Tnkase. After drug was administered, patient experienced the following side effects: pulmonary haemorrhage. Tnkase dosage: unknown. Patient died.

Tnkase Side Effects Report #5272193-8
Tnkase side effect was reported by a Pharmacist from UNITED STATES on Mar 13, 2007. Female patient was diagnosed with ischaemic stroke and was treated with Tnkase. After drug was administered, patient experienced the following side effects: pulmonary haemorrhage, renal failure, ventricular fibrillation. Tnkase dosage: 0.9 MG/KG, SINGLE, INTRAVENOUS. Patient died.


Tnkase Side Effects Report #5854739-1
Tnkase side effect was reported by a Health Professional from UNITED STATES on Aug 15, 2008. Female patient was diagnosed with coronary arterial stent insertion and was treated with Tnkase. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary haemorrhage, pulmonary thrombosis. Tnkase dosage: unknown. During the same period patient was treated with INTEGRILIN, LOVENOX. Patient was hospitalized. Patient recovered.

Tnkase Side Effects Report #5868156-1
Tnkase side effect was reported by a Health Professional from GERMANY on Aug 26, 2008. Female patient was diagnosed with coronary arterial stent insertion and was treated with Tnkase. After drug was administered, patient experienced the following side effects: pleural effusion, pulmonary haemorrhage, pulmonary thrombosis. Tnkase dosage: 50 MG, UNK. During the same period patient was treated with INTEGRILIN, LOVENOX. Patient was hospitalized. Patient recovered.